← Browse by Condition
Medical Condition

cardiac disease

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for cardiac disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cardiac disease Clinical Trials

How many clinical trials are currently recruiting for cardiac disease?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for cardiac disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cardiac disease?
cardiac disease research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cardiac disease clinical trial?
Eligibility criteria for cardiac disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 1 trial
Elsan 1 trial
Methodist Health System 1 trial
Assistance Publique - Hôpitaux de Paris 1 trial
Abbott Medical Devices 1 trial

Recruiting Clinical Trials

NCT04374799 Phase 3
Recruiting

Heparin vs Placebo for Cardiac Catheterization

Enrollment
1,623 pts
Location
Canada
Sponsor
London Health Sciences Centre ...
View Trial →
NCT06438159
Recruiting

Impact of Mindfulness-Based Stress Reduction Meditation Practice on Patients After Cardiac Rehabilitation.

Enrollment
74 pts
Location
France
Sponsor
Elsan
View Trial →
NCT07490184
Recruiting

Cardiac Clearance vs G60 Hip Frailty Index

Enrollment
100 pts
Location
United States
Sponsor
Methodist Health System
View Trial →
NCT05829993
Recruiting

Development of an Artificial Intelligence Algorithm to Detect Pathological Repolarization Disorders on the ECG and the Risk of Ventricular Arrhythmias

Enrollment
5,000 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
View Trial →
NCT07217392
Recruiting

Left Bundle Branch Area Pacing (LBBAP) PMCF Study

Enrollment
200 pts
Location
Brazil, France, Germ...
Sponsor
Abbott Medical Devices
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology